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Abstract  
FKBP5 gene interacts with childhood trauma in the risk for several stress-related psychiatric 
disorders including subclinical psychosis. The present study examined whether variation at the 
rs1360780 SNP of FKBP5 gene moderated the association between childhood abuse and 
psychotic experiences. The discovery sample included 437 individuals and the replication 
sample included 305, all drawn from the general population. In both samples, a significant 
gene-environment interaction effect was detected indicating that T allele homozygotes of the 
FKBP5 gene scored significantly higher on positive PEs after exposure to childhood abuse 
compared to CC carriers.  
 3 
 
Introduction 
Despite the fact that childhood adversity is a well-established risk factor for psychosis (1), how 
early stress exerts its long-term effects and why not everyone exposed develops negative 
outcomes later remains largely unknown. Dysregulation in the hypothalamic–pituitary–adrenal 
(HPA) axis has been proposed as a neurobiological mechanism underlying the childhood 
adversity-psychosis link (2). Therefore, it seems plausible that genetic variation affecting HPA 
axis regulation may account for differential response to childhood adversity (2). In this context, 
the organism response to stress involves the production of glucocorticoids by the adrenal axis. 
The FKBP5 is a co-chaperone which regulates glucocorticoid receptor (GR) sensitivity (3).  The 
single nucleotide polymorphism (SNP-rs1360780) in the gene encoding this co-chaperone, the 
FKBP5 gene, is associated with differential upregulation of FKBP5 and GR sensitivity (4). 
Specifically, the T-allele has been associated with enhanced expression following GR activation, 
lead to an increased GR resistance and decreased efficiency of the negative feedback of the 
stress hormone axis in healthy individuals. This results in a prolonged activation of this system. 
This dysregulated stress response has been proposed as a potential risk factor for stress-
related psychiatric disorder such as affective and anxiety disorders (3, 5-6). Interestingly, a 
recent study showed that genetic variation in the FKBP5 gene interacted with childhood 
trauma in the expression of psychosis across different familial liabilities for psychosis (7). 
However, results were partially consistent across the different samples used in the study. The 
current study aimed to replicate this finding by examining the putative moderating role of the 
rs1360780 SNP of the FKBP5 gene in the association between childhood adversity and 
psychotic experiences in two independent samples from the general population. 
 
Methods 
Sample 
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The discovery sample consisted of 437 individuals (mean age: 22.9 years; SD=5.4; 45.4% males) 
and the replication sample included 305 individuals who were recruited and assessed 
separately from discovery sample (mean age: 21.8 years; SD=2.7; 40.1% males). All participants 
were drawn from the general population and were of Spanish (Caucasian) ancestry. For more 
details about the samples see supplemental material section (SMS). 
Ethical approval was obtained from local research ethics committees. All participants provided 
written informed consent before inclusion in the study. All procedures were carried out 
according to the Helsinki Declaration.  
Measures 
The Community Assessment of Psychic Experiences (CAPE; (8)) was used to assess positive and 
negative PEs. Continuous scores were obtained for each dimension representing the frequency 
of PEs.  
Childhood abuse was assessed with the shortened version of the Childhood Trauma 
Questionnaire (CTQ; (9-10)) which evaluates emotional, physical and sexual abuse and 
emotional and physical neglect. In the current study, the subscales that assess abuse were 
combined to yield a total score of childhood abuse based on previous results (11).  
Assessment of covariates is detailed in SMS. 
Laboratory methods  
Genomic DNA was extracted from saliva samples using the Collection Kit BuccalAmp DNA 
extraction kit (Epicentre, ECOGEN, Barcelona, Spain). The SNP rs1360780 of the FKBP5 gene 
was genotyped using Applied Biosystems (AB) Taqman technology. AB assay-on-demand 
service was used to order the probes.  
Statistical Analysis 
Multiple linear regressions were conducted to test the interaction effects using STATA 10.0 for 
Windows (12). Data were analysed hierarchically in both samples. Separate models were 
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tested for positive and negative PEs as dependent variables. Firstly, the main effects of 
childhood abuse and FKBP5 gene were tested in the same model on positive PEs and negative 
PEs, separately. Secondly, the two-way interaction term, childhood abuse* FKBP5 gene was 
entered.  
Age, sex, schizotypy, cannabis and trait anxiety were included as covariates in all analyses 
(anxiety was not available in the replication sample).   
 
Results 
Rates for PEs and childhood abuse in the current samples were in agreement with previous 
reports in European and North American samples (9, 13-14).  
Hardy-Weinberg equilibrium was verified in the two samples.   
Childhood abuse was associated with positive (Discovery sample: β=.15; SE=.04; p=.001; 
Replication sample: β=.30; SE=.06; P<.001) and negative PEs (Discovery sample: β=.13; SE=.05; 
p=.007; Replication sample: β=.22; SE=.06; P<.001) in both samples. Main genetic effects were 
only found in negative PEs in the discovery sample (β=.86; SE=.30; p=.004) where TT genotype 
carriers presented the highest score for negative PEs.  
A significant interaction was detected between childhood abuse and the FKBP5 gene on 
positive PEs in the discovery (β=.21; SE=.06; p=.001) and in the replication sample (β=.53; 
SE=.08; P<.001) (Figure 1). Both results indicated that homozygotes for the T allele presented 
significantly higher scores of positive PEs when exposed to childhood abuse compared to 
homozygotes for the C allele. Heterozygotes were in an intermediate position (Figure 1) (See 
SMS for more details about the results). 
 
Discussion  
In the current study, the rs1360780 SNP of the FKBP5 gene showed to moderate the 
relationship between childhood abuse and positive PEs in two independent samples from the 
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general population. This finding replicates previous research showing that SNPs within the 
FKBP5 gene interact with the level of childhood adversity to predict the development of 
psychotic experiences (7). Furthermore, keeping in agreement with the study by Collip and 
colleagues study (7), T carriers of the rs1360780 SNP of the FKBP5 gene seem to be 
neurobiologically more vulnerable to the psychosis-inducing effects of childhood adversity 
compared to C homozygotes.  
As abovementioned, the T allele is associated with an enhanced stressor-induced expression of 
FKBP5 and impaired GR-mediated negative feedback of the HPA axis. These effects result in 
glucocorticoid resistance which is characterized by higher FKBP5 and cortisol levels prolonging 
the recovery period following stressor exposure (6). Accordingly, it has been shown that T-
allele carrier status in healthy subjects is associated with no-suppression of the HPA axis 
measured with the dexamethasone suppression (DST) and the dexamethasone-corticotropin 
releasing hormone (Dex-CRH) tests (5). Thus, it would be neurobiologically more difficult to 
recover from exposure to stress for T carriers than for C homozygotes. Furthermore, it has 
been suggested that genetic variants accounting for differential stress sensitivity such as the 
FKBP5 gene might be a common risk factor for different psychiatric disorders (5). Thus, being 
carrier of the T allele of the rs1360780 SNP of the FKBP5 gene and exposed to early stress may 
confer a general vulnerability for developing psychiatric symptoms. The final expression of this 
vulnerability, for instance, the type of psychiatric symptoms, would depend on other factors 
and circumstances which seems relevant to explore in the light of the current findings.  
The present study does have a number of limitations. Only one SNP of the FKBP5 gene was 
analyzed, however, the rs1360780 constitutes a functional polymorphism and is among the 
best investigated and characterized polymorphisms of this gene (6). A further point is that the 
retrospective measure of childhood adversity may constitute an inherent source of bias. 
Nevertheless, the CTQ is considered a valid measure of childhood adversity (10). 
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To conclude, genetic variability in the FKBP5 gene seems to be involved in differential 
sensitivity to early stress regarding the expression of positive PEs in adulthood.  
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Fig 1. Graphic representation of the interaction effect between childhood abuse and the FKBP5 gene rs1360780 SNP on positive psychotic experiences (PEs) 
in: A) discovery sample (n=437) and, B) replication sample (n=305). In the discovery sample the covariates were age, sex, schizotypal personality, cannabis 
use and trait anxiety. In the replication sample the covariates were age, sex, schizotypal personality and cannabis. Effects of childhood abuse on positive PEs 
showed to be moderated by the rs1360780 SNP of the FKBP5 gene in both samples. Results indicate that carriers of the T allele exposed to childhood abuse 
have significantly higher scores on positive PEs compared to homozygotes for the C allele. Highest scores on positive PEs were presented by the TT genotype 
carriers exposed to childhood abuse.  
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